Despite uncertainty remaining in the overall market, orthopedic companies continue to make bold strategic moves through their product portfolios and industry partnerships. The highly-rated executive keynote panel returned to OMTEC to share how companies across orthopedics are balancing the day’s issues while positioning themselves as leaders in the market.
Curt Hartman (CONMED), Brady Shirley (Enovis), Rebecca Whitney (ZimVie) and Eric Major (formerly K2M and Stryker) shared their thoughts on a range of topics, including market recovery, supply chain obstacles, technology trends, ASC strategies and the future orthopedic landscape. These executives speak at OMTEC during an evolutionary period for their companies. ZimVie was spun off from Zimmer Biomet, becoming a standalone spine and dental business. Enovis has been on an acquisition spree in its efforts to build a $1 billion joint replacement company. CONMED recently expanded into the foot and ankle market. Stryker was integrating K2M at the start of the pandemic.
Matt O’Brien, Senior Research Analyst and Managing Director, Piper Sandler
Matt O’Brien is a Senior Research Analyst and Managing Director at Piper Sandler, covering medical technology and devices. Before joining Piper in 2014, Mr. O’Brien covered medical technology at William Blair for 10 years. His additional work experience includes five years of middle-market investment banking financial advisory work and two years at a healthcare manufacturing and distribution company. Mr. O’Brien holds an MBA from the University of Chicago Booth School of Management and a BS in Finance from DePaul University.
Curt Hartman, President and CEO, CONMED
Curt R. Hartman is the Chair of the Board, President and Chief Executive Officer of CONMED Corporation, positions he has held since 2014. Prior to CONMED, he had a 22-year career at Stryker.
During his tenure with Stryker, Mr. Hartman served as Interim Chief Executive Officer from February 2012 to October 2012 and as Vice President and Chief Financial Officer from April 2009 to October 2012. Mr. Hartman initially joined Stryker as a Manufacturing Engineer. He subsequently held roles of increasing responsibility to include Unit Supervisor, Production Unit Manager, Director of Information Technology, National Accounts Director and Vice President, General Manager and Global President of the Instruments Division.
Brady Shirley, President and COO, Enovis
Brady Shirley is President and COO of Enovis (formerly DJO Global), a leading company that provides products and integrated technologies that address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation. Prior to his current position, Mr. Shirley served as President of DJO Surgical.
From 2009 to 2013, Mr. Shirley was the CEO and Director of Innovative Medical Device Solutions (IMDS), where he managed the integration of four companies, consolidated the capital structure and led a successful sale of the business in 2013. From December 1992 to August 2009, Mr. Shirley had several key leadership positions with Stryker Corporation, including President of Stryker Communications and Senior Vice President of Stryker Endoscopy.
Rebecca Whitney, Senior Vice President and President, Global Spine, ZimVie
Rebecca Whitney was appointed Senior Vice President and President, Global Spine, of ZimVie in April 2021. Previously, Ms. Whitney served as Vice President, ASC/Outpatient Solutions and Efficient Care of Zimmer Biomet from July 2019 until April 2021. She joined Zimmer Biomet in June 2014 as Senior Director of Global Marketing for the Spine organization. She then took on expanded leadership roles within the Spine organization, first as Vice President of Global Marketing and then as General Manager, Global Spine, a position she held until July 2019.
Ms. Whitney also has strong strategic commercial leadership experience in the medical device and healthcare sectors from BD Medical Systems, CR Bard, Galen Partners and Covidien.
Eric Major, Entrepreneur and Advisor, Major Advisory Group
Eric Major is an experienced entrepreneur, chief executive, and chairman with a passion for entrepreneurship and disruptive technologies. His experience includes startup development, early-stage Angel and Private Placement funding, Venture Capital, Private Equity, IPO, public company management, public and private Board leadership, global operations, M&A, and integration strategy and management.
Mr. Major was a founder of K2M and served as the company’s Chairman, President and CEO when Stryker Spine purchased K2M for $1.4 billion in 2018. After the acquisition, Mr. Major led Stryker Spine.
He is currently an advisor to VC and PE firms and numerous early-stage technology ventures. Mr. Major previously served on the Board of Directors of the Medical Device Manufacturers Association and AdvaMed CEO Advisory Council.